第58届欧洲糖尿病研究协会年会纪要:糖尿病及代谢性疾病研究进展  

The 58^(th) annual meeting of the European Association for the Study of Diabetes:advances in the research of diabetes mellitus and metabolic diseases

作　　者：严晋华[1] 张惠杰 Yan Jinhua;Zhang Huijie(Department of Endocrinology and Metabolism,the Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China;Department of Endocrinology and Metabolism,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China)

机构地区：[1]中山大学附属第三医院内分泌科,广州510630 [2]南方医科大学南方医院内分泌科,广州510515

出　　处：《中华内分泌代谢杂志》2023年第4期361-367,共7页Chinese Journal of Endocrinology and Metabolism

摘　　要：2022年欧洲糖尿病研究协会(European Association for the Study of Diabetes,EASD)第58届年会于2022年9月19日至23日在瑞典斯德哥尔摩,采取线上结合线下的形式召开。本次大会关注糖尿病及代谢性疾病的最新研究进展,包含主报告、口头报告、摘要等多种展示形式。本文聚焦于重要奖项的颁布及其专题讲座、2型糖尿病高血糖管理共识以及糖尿病防治营养指南,同时对糖尿病及其他代谢性疾病的重磅研究成果及其他前沿进展进行概述,旨在为我国糖尿病及其他相关代谢疾病的临床管理提供参考。The 58^(th) annual scientific meeting of the European Association for the Study of Diabetes(EASD)was held in Stockholm in the form of online and offline combination from 19 to 23,September 2022.This meeting released the latest research findings of diabetes and metabolism through symposiums,oral presentations and discussions,and other presentation formats.The following highlights spotlight the 2022 EASD awards,consensus report on the management of hyperglycemia in type 2 diabetes,updated dietary guidelines for the treatment and prevention of diabetes,and other academic progress and research hot points in diabetes mellitus and metabolic diseases,aiming to provide references for the clinical management of diabetes mellitus and other related metabolic diseases in China.

关 键 词：糖尿病 代谢性疾病 欧洲糖尿病研究协会年会 

分 类 号：R587.1[医药卫生—内分泌] R589[医药卫生—内科学]